JBF Capital’s Filana Therapeutics FLNA Stock Holding History

JBF Capital’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,000	Closed	-$46K	–	122
2020 Q3	$46K	Buy	+4,000	New	+$18K	0.01%	111

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JBF Capital's FLNA Position: Q4 2020 in Review

JBF Capital sold out of Filana Therapeutics (FLNA) in Q4 2020, closing a stake of 4,000 shares — an estimated $46K sold.

JBF Capital first reported a position in FLNA in Q3 2020 and held it in 1 quarter. The position peaked at $46K in Q3 2020. 79 funds tracked by Wall St. Rank hold FLNA as of Q4 2020.

JBF Capital reported no remaining Filana Therapeutics position as of Q4 2020 after selling out during the quarter.
JBF Capital sold 4,000 Filana Therapeutics shares in Q4 2020, an estimated $46K.
JBF Capital first reported a position in Filana Therapeutics in Q3 2020 and held it in 1 quarter.
JBF Capital's Filana Therapeutics position peaked at $46K in Q3 2020.
79 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2020.

Based on JBF Capital's 13F filing for Q4 2020, filed 11 Feb 2021.